Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 211

Results For "SEC"

2371 News Found

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Biotech | October 14, 2021

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations


FICCI annual healthcare conference from Oct. 20-22nd 2021
Events | October 14, 2021

FICCI annual healthcare conference from Oct. 20-22nd 2021

This is a virtual event and the theme is `Transforming Healthcare beyond Covid’


American Diabetes Association acknowledges Breath Well-being diabetes reversal programme
News | October 13, 2021

American Diabetes Association acknowledges Breath Well-being diabetes reversal programme

BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes


HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
Digitisation | October 12, 2021

HCL expands its partnership with Google Cloud to focus on healthcare and life sciences

HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs


Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


Cyprium Therapeutics and Sentynl, a Zydus subsidiary announce positive data for CUTX-101, CuHis
Biotech | October 09, 2021

Cyprium Therapeutics and Sentynl, a Zydus subsidiary announce positive data for CUTX-101, CuHis

The rolling submission to the U.S. FDA will begin in the fourth quarter of this year


Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation
Biotech | October 09, 2021

Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation

Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022


Sanofi says positive results from flu vaccine with mRNA booster study
Biotech | October 08, 2021

Sanofi says positive results from flu vaccine with mRNA booster study

The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older


U.S. FDA clears Venclose Maven to treat incompetent perforator veins
Medical Device | October 07, 2021

U.S. FDA clears Venclose Maven to treat incompetent perforator veins

Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years